Mainz Biomed (MYNZ) Change in Account Payables (2021 - 2025)
Historic Change in Account Payables for Mainz Biomed (MYNZ) over the last 5 years, with Q2 2025 value amounting to $1.1 million.
- Mainz Biomed's Change in Account Payables fell 6058.47% to $1.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.1 million, marking a year-over-year decrease of 6058.47%. This contributed to the annual value of $2295.1 billion for FY2024, which is 7207224310.22% up from last year.
- Latest data reveals that Mainz Biomed reported Change in Account Payables of $1.1 million as of Q2 2025, which was down 6058.47% from $2295.1 billion recorded in Q4 2024.
- Mainz Biomed's Change in Account Payables' 5-year high stood at $2295.1 billion during Q4 2024, with a 5-year trough of -$390167.0 in Q1 2023.
- Over the past 5 years, Mainz Biomed's median Change in Account Payables value was $1.2 million (recorded in 2022), while the average stood at $191.3 billion.
- Per our database at Business Quant, Mainz Biomed's Change in Account Payables crashed by 69178.98% in 2023 and then surged by 47352895372.92% in 2024.
- Mainz Biomed's Change in Account Payables (Quarter) stood at $784786.0 in 2021, then soared by 139.47% to $1.9 million in 2022, then tumbled by 74.21% to $484671.0 in 2023, then skyrocketed by 473528953.73% to $2295.1 billion in 2024, then plummeted by 100.0% to $1.1 million in 2025.
- Its Change in Account Payables stands at $1.1 million for Q2 2025, versus $2295.1 billion for Q4 2024 and $2.9 million for Q2 2024.